Robert E. Hoffman - 15 May 2025 Form 4 Insider Report for CytoDyn Inc. (CYDY)

Reporting relationship: Chief Financial Officer
Issuer ticker: CYDY
Reported as of: 15 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 May 2025, 20:31:53 UTC
Prior SEC filing: 02 Apr 2025
Next SEC filing: 02 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Tyler Blok, attorney-in-fact for Robert E. Hoffman

Key filing fact

Robert E. Hoffman filed Form 4 for CytoDyn Inc. (CYDY) on 22 May 2025.

Key facts

This page summarizes Robert E. Hoffman's Form 4 filing for CytoDyn Inc. (CYDY).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 22 May 2025, 20:31.

Change

Previous filing in this sequence was filed on 02 Apr 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001166288 Primary reporting owner

Hoffman Robert E.

Relationship: Chief Financial Officer
Address: 1111 MAIN STREET, SUITE 660, VANCOUVER
Signature: /s/ Tyler Blok, attorney-in-fact for Robert E. Hoffman
Signature date: 22 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CYDY transaction Derivative

Non-qualified stock option (right to buy)

Award

Transaction value: $0
Shares: +1,000,000
Change %
Price: $0.000000
Shares after: 1,000,000
Date: 15 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,000,000
Exercise price: $0.4100
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This grant was approved by the Company's Compensation Committee effective May 15, 2025, pursuant to the Issuer's 2012 Equity Incentive Plan, as amended (the "Plan").

Footnote F2

250,000 shares will vest on May 15, 2026, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Plan ) from May 2026 through April 2029.